New immunological potential markers for triple negative breast cancer: IL18R1, CD53, TRIM, Jaw1, LTB, PTPRCAP
Paolo Marchetti(Sapienza University of Rome), Maria Valeria Catani(University of Rome Tor Vergata)
Cited by 23
Related Papers
Platelet-Derived miR-126-3p Directly Targets AKT2 and Exerts Anti-Tumor Effects in Breast Cancer Cells: Further Insights in Platelet-Cancer Interplay
|International Journal of Molecular Sciences|2022|31